Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Nature Communications|January 21, 2025
Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studiesJesper D Gunst, Jesal Gohil, Johanthan Z Li, et al.
Journal of Translational Medicine|December 14, 2011
Definition of the viral targets of protective HIV-1-specific T cell responsesBeatriz Mothe, Anuska Llano, Javier Ibarrondo, et al.
The Journal of Infectious Diseases|October 6, 2022
Limited Humoral and Specific T-Cell Responses After SARS-CoV-2 Vaccination in PWH With Poor Immune ReconstitutionSusana Benet, Oscar Blanch-Lombarte, Erola Ainsua-Enrich, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 2015
Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1Beatriz Mothe, Nuria Climent, Montserrat Plana, et al.
Iscience|November 2, 2022
Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individualsErola Ainsua-Enrich, Núria Pedreño-Lopez, Carmen Bracke, et al.
JCI Insight|July 9, 2024
Vedolizumab and ART in recent HIV-1 infection unveil the role of α4β7 in reservoir sizeMaria Reyes Jimenez-Leon, Carmen Gasca-Capote, Cristina Roca-Oporto, et al.
Journal of Virology|November 24, 2017
Differential Immunodominance Hierarchy of CD8<sup>+</sup> T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 InfectionEmily Adland, Matilda Hill, Nora Lavandier, et al.
Nature Communications|March 4, 2025
Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trialLucia Bailón, José Moltó, Adrian Curran, et al.
Scientific Reports|March 22, 2025
SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial)Sofía Sábato, Susana Benet, Angela J Rogers, et al.
Pageof 10